This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
ABSTRACT Atrialflutter (AFL), defined as macro-re-entrant atrial tachycardia, is associated with debilitating symptoms, stroke, heart failure, and increased mortality. Atypical AFL is a heterogenous group of re-entrant atrial tachycardias that most commonly occur in patients with prior heart surgery or catheter ablation.
Atypical AtrialFlutter (AAFL) prevalence is increasing due to the escalating Atrial Fibrillation (AF) ablations and cardiac surgeries. We wanted to explore the outcome of the AAFL ablation, considering the recent changes in mapping and ablation.
The ECG was interpreted as showing atrialflutter with 2:1 conduction. The heart rate could be compatible with that of a 2:1 conducted atrialflutter. Also, lead I could give the initial impression of showing flutter waves. She presented to the emergency department after a couple of days of chest discomfort.
ABSTRACT Background Atrial fibrillation and atrialflutter are relatively rare in young people and the incidence of thromboembolic complications is unknown. These issues contribute to the limited utility of present guidelines regarding anticoagulation in this population.
The trial will evaluate the outcomes of therapy provided with the FARAPULSE PFA System versus AADs, including device-or procedure-related adverse events, the rates of freedom from AF, atrialflutter, or atrial tachycardia, as well as AF burden – a measurement of the amount of AF an individual experiences.
Procedures were most commonly for atrial fibrillation (52.4%), atrialflutter (10.9%), and atrioventricular nodal re-entrant tachycardia (10.1%). Results 1089 patients were included: MC 718 (65.9%); Fo8 HT 105 (9.6%); Fo8 MOD 266 (24.4%). 01; minor: MC 16.5%, Fo8 HT 12.0%, Fo8 MOD 7.4%, p =.002).
Abstract Introduction Cavo-tricuspid isthmus (CTI) dependent atrialflutter (AFL) is one of the most common atrial arrhythmias involving the right atrium (RA) for which radiofrequency catheter ablation has been widely used as a therapy of choice.
The positive F wave in lead V1 changed during entrainment from the right atrial appendage (RAA) during typical atrialflutter (AFL). Abstract Introduction Typical atrialflutter (AFL) is a macroreentrant tachycardia in which intracardiac conduction rotates counterclockwise around the tricuspid annulus.
said Nick Spadea-Anello, president, Electrophysiology, Boston Scientific. director of electrophysiology, Mount Sinai Fuster Heart Hospital , New York. physicians and patients alike," Reddy added.
Abstract Introduction Atrial fibrillation and atrialflutter originating from the donor s heart is a commonly reported complication post heart transplant. Case A 47-year-old male presented with atrial tachycardia 6 months post heart transplant. This arrhythmia was successfully terminated with radiofrequency ablation.
Circulation: Arrhythmia and Electrophysiology, Ahead of Print. BACKGROUND:Inflammation may promote atrial fibrillation (AF) recurrence after catheter ablation. mg twice daily or placebo for 10 days. mg twice daily or placebo for 10 days. The first dose of the study drug was administered within 4 hours before ablation.
Available study and registry data as well as case reports concerning utilization of the QDOT MICRO™ Catheter for the treatment of cardiac arrhythmias including AF, focal and macroreentry atrial tachycardia, typical atrialflutter by cavotricuspid isthmus block, premature ventricular contractions, and accessory pathways were reviewed and summarized.
Abstract Introduction The use of flecainide and propafenone for medical cardioversion of atrial fibrillation (AF) and atrialflutter/intra-atrial reentrant tachycardia (IART) is well-described in adults without congenital heart disease (CHD).
Abstract Background Dofetilide is a class III antiarrhythmic agent approved for the treatment of atrial fibrillation and atrialflutter. Given the efficacy of other class III agents, it has been used off-label for the treatment of premature ventricular complexes (PVCs) and ventricular tachycardias (VTs).
2** Furthermore, the primary effectiveness endpoint (PEE) of acute pulmonary vein isolation and 12-month freedom from atrial arrhythmia recurrence (AF, Atrial Tachycardia, or AtrialFlutter) was 75.6%. iii] The study reported a low fluoroscopy time of 7.8
On the other hand, non-FAAM-guided ablation was performed via linear ablation, complex fractionated atrial electrogram ablation, superior vena cava isolation, and focal ablation according to the location of the non-PV foci. The primary endpoints were AF recurrence, atrialflutter, and/or atrial tachycardia.
The Differential Diagnosis is: SVT with aberrancy(#) [AVNRT vs. WPW (also called AVRT*)] Atrialflutter with 1:1 conduction, with aberrancy VT coming from the anterior fascicle ( fascicular VT )@ *AVRT = AV Reciprocating Tachycardia (Tachycardic loop that uses both the AV node and an accessory pathway.
There is atrial activity before every QRS, but that activity has negative polarity, so it is not sinus rhythm. There are clearly no flutter waves, so it is not atrialflutter (a "macro-reentrant" atrial tachycardia) Is it AVNRT originating at the superior pole of the AV node, resulting in a retrograde P-wave before the QRS?
Methods The primary effectiveness endpoint (PEE) was 12-month freedom from documented atrial fibrillation/atrialflutter/atrial tachycardia plus freedom from acute procedural failure, nonstudy catheter failure, repeat ablation failure, direct current cardioversion (DCCV), and Class I/III antiarrhythmic drug (AAD) failure.
Electrophysiologic studies were performed in selected patients only as clinically appropriate. Arrhythmias as a cause of syncope were diagnosed by cardiac monitoring or electrophysiologic testing. Holter monitoring, or intracardiac electrophysiologic studies, alone or in combination (diagnostic yields, 5% to 35%).
IntroductionThe precise pathophysiology of common atrialflutter remains imperfectly known. No conduction slowing is present.ConclusionsCommon atrialflutter initiates when functional unidirectional conduction block occurs on the septal cavotricuspid isthmus.
ABSTRACT Typical atrialflutter (AFL), defined as cavotricuspid isthmus (CTI)-dependent macro-re-entrant atrial tachycardia, often causes debilitating symptoms, and is associated with increased incidence of atrial fibrillation, stroke, heart failure, and death.
The Affera system was designed to address procedural challenges faced by the electrophysiology community while maintaining a high standard of safety and efficacy for patients. tim.hodson Wed, 10/30/2024 - 13:42 Oct. With this approval, Medtronic now offers two PFA technologies available for patients with Afib.
Methods and Results ATA recurrence was defined as 30s recurrence of atrial fibrillation, atrialflutter or atrial tachycardia after a 90-day blanking period and through 12-months. Univariate and multivariable Cox regression analysis (with ATA recurrence as an endpoint) was performed to identify CBA responders.
After the blanking period of 3 months, 62/109 patients were in sinus rhythm (SR) (57%), 33/109 were in AF (30.2%), 8/109 were in left atrialflutter (AFL) (7.3%), and six were in right AFL (5.5%). Accordingly, 109 patients who underwent MPA as first-line therapy were included.
Cardioversion is most beneficial for reentrant arrhythmias ( e.g. VT, atrialflutter, AVNRT, atrial fibrillation) because it terminates the reentry circuit. Atrial tachycardia can occasionally be due to reentry, but reentrant circuits usually have a more stable cycle length without so much beat to beat variability.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content